Papers
6
Total Citations
146
H-Index
4
About
No biography available yet.
Research Focus
Internal medicine6 · 146 citations
Medicine6 · 146 citations
Cancer6 · 146 citations
Surgery5 · 144 citations
Stage (stratigraphy)2 · 95 citations
Esophagectomy5 · 84 citations
Esophageal cancer5 · 84 citations
Dissection (medical)3 · 80 citations
Lymph node3 · 80 citations
Chemotherapy3 · 66 citations
Neoadjuvant therapy2 · 64 citations
Esophageal squamous cell carcinoma2 · 64 citations
Key Achievements
4
H-Index
6
Papers
146
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001)
62 citations · 2022
📈 Most Prolific Year: 2020 (3 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: Tianjin Medical University Cancer Institute and Hospital
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
Key Collaborators
HJHongjing Jiang5 shared papersJYJie Yue5 shared papersCCChuangui Chen4 shared papersXSXiaobin Shang4 shared papersLGLei Gong3 shared papersZMZhao Ma3 shared papersZYZhentao Yu2 shared papersCZChen Zhang2 shared papersPTPeng Tang2 shared papersXZXijiang Zhao1 shared papersPRPeng Ren1 shared papersRLRunmei Li1 shared papersXLXiangming Liu1 shared papersLLLiang Liu1 shared papersGZGang Zhao1 shared papersBMBin Meng1 shared papersZMZhao Ma1 shared papersZYZhentao Yu1 shared papersWZWei‐Hong Zhang1 shared papersZCZuoyu Chen1 shared papers
Not generated yet